Advances in childhood diabetes 2013

摘要

The opening sessions on each day of this 4-day meeting showcased plenary reviews of current issues by international speakers - prevention of childhood diabetes, p-cell replacement, neurocognitive dysfunction and long-term complications. A second plenary on the final day took on the holy grail of insulin therapy - the closed loop. T Wilkin (Exeter, UK), M Knip (Helsinki, Finland) and A Lernmark (Malmo, Sweden) tackled the issue of prevention in Type 1 diabetes (T1D). Wilkin summarized the emerging - and often controversial - evidence for insulin resistance as the primary driver for T1D, as it is for Type 2 diabetes.